Arkolith/Insider Trading/OCUP/Form 4

Jayagopal Ashwath

Chief Scientific & Dev. Ofc.Ocuphire Pharma, Inc. (OCUP) · full profile →Form 4 · filed May 24, 2024
Net Buying
Open-Market Buys
$6K
Open-Market Sells
$0
Net Open-Market Flow
$6K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 22, 2024Buy(P)4K$1.77$6K79K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-001625) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML